Marketscreener, stock market website
d95b6d8b4d9.auepc5hBFeIBw2UWhOXnHLJFdzwQGh_zJ8o-625JD-U.GrjiN8k0fbp3l0hSzoygT4oXRW1CKlzFf7lbiBovNt07v8AB4DdYlUq6VQ

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    United Kingdom
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    ASML HOLDING N.V.
    ORACLE CORPORATION
    VOLKSWAGEN AG
    MICROSOFT CORPORATION
    EQUINOR ASA
    RIO TINTO PLC
    VERIZON COMMUNICATIONS, INC.
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    S&P 500
    NASDAQ 100
    TSX COMP
    SHANGHAI COMPOSITE
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    GBP / USD
    GBP / EUR
    GBP / CHF
    GBP / RUB
    GBP / SEK
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation, and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Sectors
    Most Read News
    Hot News
  • Analysis
    All Articles
    Must Read
    Equities Analysis
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
  • Calendar
    Economic Calendar
    Company calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Top ROE
    Trend-Following Stocks
    Quality stocks at a reasonable price
    Undervalued stocks
    Low capital intensity
    Yield stocks
    Investment Themes
    Homepage
    Semiconductors
    Water
    The genomic revolution
    Europe's family businesses
    Artificial Intelligence
    Smart home
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Millennials
    Boats
    The SPAC
    Metaverse
    Cannibal companies
    In Vino Veritas
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • United Kingdom
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • ASML HOLDING N.V.
      • ORACLE CORPORATION
      • VOLKSWAGEN AG
      • MICROSOFT CORPORATION
      • EQUINOR ASA
      • RIO TINTO PLC
      • VERIZON COMMUNICATIONS, INC.
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
      • S&P 500
      • NASDAQ 100
      • TSX COMP
      • SHANGHAI COMPOSITE
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • GBP / USD
      • GBP / EUR
      • GBP / CHF
      • GBP / RUB
      • GBP / SEK
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation, and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Sectors
    • Most Read News
    • Hot News
  • Analysis
    • All Articles
    • Must Read
    • Equities Analysis
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
  • Calendar
    • Economic Calendar
    • Company calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Top ROE
      • Trend-Following Stocks
      • Quality stocks at a reasonable price
      • Undervalued stocks
      • Low capital intensity
      • Yield stocks
    • Investment Themes
      • Homepage
      • Semiconductors
      • Water
      • The genomic revolution
      • Europe's family businesses
      • Artificial Intelligence
      • Smart home
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Millennials
      • Boats
      • The SPAC
      • Metaverse
      • Cannibal companies
      • In Vino Veritas
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock MSB MESOBLAST LIMITED
Add to a list

Mesoblast Limited

Equities

MSB

AU000000MSB8

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
05:10:27 16/01/2026 GMT
5-day change 1st Jan Change
2.640 AUD -2.22% Intraday chart for Mesoblast Limited -14.01% -2.94%
01-16 ASX Biggest Losers MT
01-14 ASX Biggest Losers MT
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas
Company
Profile Governance Share ownership Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Mesoblast Says US FDA Schedules Meeting in Early December to Discuss Data from Chronic Low Back Pain Study

Published on 11/05/2025 at 03:10 am GMT

MT Newswires
Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
mtnewswires logo
© MT Newswires - 2025
Share

Latest news about Mesoblast Limited

01-16 ASX Biggest Losers MT
01-14 ASX Biggest Losers MT
01-14 Mesoblast Likely to Complete More Ryoncil Therapies than Expected in Fiscal 2026, Says Jefferies MT
01-13 ASX Biggest Losers MT
01-09 Mesoblast Shares Rise After Ryoncil Sales Jump in Q4 MT
01-09 Mesoblast Says US Revenue From Sale of Cell Therapy Rises Quarter-on-Quarter in December 2025 Quarter; Shares Reach Five-Year Peak MT
01-09 Mesoblast says Ryoncil sales for quarter increase 60% to $35.1M RE
01-09 ASX Biggest Gainers MT
01-09 ASX Most Active Stocks MT
01-08 Mesoblast Says US Revenue From Sale of Cell Therapy Rises Quarter-on-Quarter in December 2025 Quarter MT
01-08 ASX Biggest Gainers MT
01-02 Mesoblast Limited Announces Changes to Its Board CI
01-02 Mesoblast Chair Jane Bell to Retire; Successor Named MT
01-02 Australian Shares Flat; Nickel Industries Says South Korean Manufacturer to Acquire 10% Stake in Indonesia Project MT
01-02 Mesoblast Says Chair to Retire, Successor Appointed; Shares Up 3% MT
01-02 Mesoblast appoints Philip Facchina as non-executive chair RE
01-02 ASX Biggest Gainers MT
01-01 Mesoblast Limited Announces Changes to Board of Directors CI
12-30 Sector Update: Health Care Stocks Edge Lower Tuesday Afternoon MT
12-30 Sector Update: Health Care Stocks Edge Higher Premarket Tuesday MT
12-30 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Fed Meeting Minutes MT
12-30 Sector Update: Health Care MT
12-30 Mesoblast Refinances Debt With New $125 Million Credit Facility MT
12-30 Mesoblast to Release 10.2 Million Shares From Voluntary Escrow MT
12-30 ASX Biggest Gainers MT

Chart Mesoblast Limited

Chart Mesoblast Limited
MSB: Dynamic Chart

Company Profile

Logo Mesoblast Limited
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.
Employees
81
Sector
Biotechnology & Medical Research
Calendar
02-25 - Q2 2026 Earnings Release (Projected)
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI
BBB
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.640AUD
Average target price
3.830AUD
Spread / Average Target
+45.08%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Currencies & Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area
  1. Stock Market
  2. Stock Market News
  3. Mesoblast Says US FDA Schedules Meeting in Early December to Discuss Data from Chronic Low Back Pain Study
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,300,000members

+ 1,300,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
The best tools reserved for subscribers to boost the performance of your investments!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong